These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18777611)

  • 1. Aliskiren combined with losartan in diabetes and nephropathy.
    Kamoi K
    N Engl J Med; 2008 Sep; 359(10):1069; author reply 1069-70. PubMed ID: 18777611
    [No Abstract]   [Full Text] [Related]  

  • 2. Aliskiren combined with losartan in diabetes and nephropathy.
    Anderson S; Komers R
    N Engl J Med; 2008 Sep; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
    [No Abstract]   [Full Text] [Related]  

  • 3. Aliskiren combined with losartan in diabetes and nephropathy.
    Lindner T
    N Engl J Med; 2008 Sep; 359(10):1068-9; author reply 1069-70. PubMed ID: 18777612
    [No Abstract]   [Full Text] [Related]  

  • 4. Aliskiren and dual therapy in type 2 diabetes mellitus.
    Ingelfinger JR
    N Engl J Med; 2008 Jun; 358(23):2503-5. PubMed ID: 18525047
    [No Abstract]   [Full Text] [Related]  

  • 5. Aliskiren combined with losartan in diabetes and nephropathy.
    Panesar M; Damodar A
    N Engl J Med; 2008 Sep; 359(10):1068; author reply 1069-70. PubMed ID: 18768954
    [No Abstract]   [Full Text] [Related]  

  • 6. Current concepts: renin inhibition in the treatment of hypertension.
    Gradman AH; Pinto R; Kad R
    Curr Opin Pharmacol; 2008 Apr; 8(2):120-6. PubMed ID: 18308634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aliskiren attenuates proteinuria in mice with lupus nephritis by a blood pressure-independent mechanism.
    Yen TH; Yang HY; Yeh YH; Chu PH; Wen CJ; Fu JF; Wang IK; Liang CC; Chang CT; Chen KH; Tian YC; Hung CC; Lin JL; Yang CW
    Lupus; 2013 Feb; 22(2):180-9. PubMed ID: 23257405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren for hypertension: just another option or something truly unique?
    Lee S
    S D Med; 2007 Oct; 60(10):405-6. PubMed ID: 18019776
    [No Abstract]   [Full Text] [Related]  

  • 9. Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria.
    Nakamura T; Sato E; Amaha M; Kawagoe Y; Maeda S; Yamagishi S
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):122-7. PubMed ID: 21946392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aliskiren and losartan trial in non-diabetic chronic kidney disease.
    Woo KT; Choong HL; Wong KS; Tan HK; Foo M; Fook-Chong S; Lee EJ; Anantharaman V; Lee GS; Chan CM
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):515-22. PubMed ID: 24742970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren: a novel renin inhibitor for hypertension.
    Parmar DM; Jadav SP
    Indian J Physiol Pharmacol; 2007; 51(1):99-101. PubMed ID: 17877301
    [No Abstract]   [Full Text] [Related]  

  • 12. The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskiren.
    Ménard J; Azizi M
    J Hypertens; 2007 Sep; 25(9):1775-82. PubMed ID: 17762637
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardio-renal protection with aliskiren, a direct renin inhibitor, in the ASPIRE HIGHER program.
    Lee HY; Oh BH
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):251-7. PubMed ID: 19296761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliskiren (Tekturna) for hypertension.
    Med Lett Drugs Ther; 2007 Apr; 49(1258):29-31. PubMed ID: 17415282
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial.
    Lizakowski S; Tylicki L; Renke M; Rutkowski P; Heleniak Z; Sławińska-Morawska M; Aleksandrowicz E; Łysiak-Szydłowska W; Rutkowski B
    Int Urol Nephrol; 2012 Dec; 44(6):1763-70. PubMed ID: 23326865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renin inhibitors. Aliskiren for the treatment of high blood pressure].
    Heinzl S
    Med Monatsschr Pharm; 2007 Sep; 30(9):320-1. PubMed ID: 17912871
    [No Abstract]   [Full Text] [Related]  

  • 17. Aliskiren: a novel renin inhibitor for hypertension.
    Tayal V; Kalra BS
    Indian Heart J; 2008; 60(1):69-72. PubMed ID: 19212031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
    Pimenta E; Oparil S
    Cardiol Clin; 2008 Nov; 26(4):527-35. PubMed ID: 18929229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of glycaemic control on the effect of direct renin inhibition in the AVOID study.
    Persson F; Lewis JB; Lewis EJ; Rossing P; Hollenberg NK; Parving HH
    J Renin Angiotensin Aldosterone Syst; 2012 Jun; 13(2):250-3. PubMed ID: 22345094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren.
    Brown MJ
    Circulation; 2008 Aug; 118(7):773-84. PubMed ID: 18695203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.